Results 41 to 50 of about 108,150 (283)
The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey
Clinical and Translational Radiation OncologyA survey regarding utilisation of brachytherapy was distributed to European brachytherapy professionals. Eighty replies from 26 countries were received, two of which were outside Europe. The replies showed that brachytherapy is still widely used.
J.G. Johansen +16 more
doaj +1 more source
Dermatology and Therapy, 2023 Introduction Basal cell carcinoma of the facial region remains a challenge for contemporary oncology due to the presence of aesthetic regions and critical organs.
Tomasz Krzysztofiak +4 more
doaj +1 more source
Subglottic Stenosis After Radioactive Iodine Treatment for Graves' Disease: A Case Report
Head &Neck, EarlyView.ABSTRACT Background Subglottic stenosis (SGS) is a narrowing of the airway below the glottis and may be congenital or acquired. While prolonged intubation is the most common cause of acquired SGS, other etiologies remain incompletely understood. Methods A 37‐year‐old woman presented with a four‐year history of mild progressive stridor, dysphonia, and ...
Claire Ettlin +3 more
wiley +1 more source
iNew Medicine, EarlyView.This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li +4 more
wiley +1 more source
Interstitial brachytherapy for orbital soft tissue sarcoma: an innovative technique
Journal of Contemporary Brachytherapy, 2017 Purpose: To report an innovative technique of interstitial brachytherapy developed for treatment of orbital soft tissue tumors. Material and methods : A 4-month-old child diagnosed with rhabdomyosarcoma of orbit was treated with multiagent ...
Siddhartha Laskar +3 more
doaj +1 more source
Insights into Imaging, 2022 Key points 125I brachytherapy is a treatment for locally recurrent HCC after ablation. 125I brachytherapy combined with ablation may improve tumor control. Vascular invasion, multiple lesions, and AFP are prognostic risk factors.
Wenliang Zhu +7 more
doaj +1 more source
Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT). [PDF]
, 2013 The aim of this study was to report 3-year outcomes of toxicity, cosmesis, and local control using a once daily fractionation scheme (49.95 Gy in 3.33 Gy once daily fractions) for accelerated partial breast irradiation (APBI) using three-dimensional ...
Daroui, Parima +5 more
core +2 more sources
GammaTile® brachytherapy in the treatment of recurrent glioblastomas [PDF]
, 2021 Dominic J. Gessler +15 more
openalex +1 more source
Hypervision Proton Surgery: The Future Direction of Proton Therapy
iNew Medicine, EarlyView.ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley +1 more source
A nomogram to determine required seed air kerma strength in planar 131 Cesium permanent seed implant brachytherapy [PDF]
, 2019 Purpose: Intraoperatively implanted Cesium-131 ( 131 Cs) permanent seed brachytherapy is used to deliver highly localized re-irradiation in recurrent head and neck cancers.
Bar-Ad, Voichita +4 more
core +1 more source